http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107412777-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-216 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5025 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5025 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-216 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 |
| filingDate | 2017-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-107412777-B |
| titleOfInvention | Anti-tumor combined medicine and application thereof in preparing anti-cancer medicine |
| abstract | The invention discloses an anti-tumor combined medicament and application thereof in preparing an anti-cancer medicament, wherein the combined medicament comprises a first preparation and a second preparation, and the anti-tumor combined medicament comprises 10-40 parts of the first preparation and 0.1-10 parts of the second preparation in parts by weight. The invention also discloses application of chlorogenic acid in preparing an anticancer drug toxic and side effect inhibitor, wherein the anticancer drug is a BCR-ABL small molecule inhibitor. The technical scheme of the invention can improve the targeting property of the BCR-ABL small molecular inhibitor in chronic granulocytic leukemia, reduce the toxic and side effects of the BCR-ABL small molecular inhibitor and reverse the drug resistance of the BCR-ABL small molecular inhibitor. |
| priorityDate | 2017-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 178.